Abstract: An embodiment of the present invention provides a method of detecting user presence, comprising registering a client associated with the user on a host associated with the user and setting up a wireless communication pairing, wherein while setting up the pairing, the client measures the host wireless communication power and uses it as calibration threshold for distance detection, and wherein the client measures a beacon power of the host radio and when the beacon power is above a threshold, the client is determined to be proximate to the host.

Abstract: The instant application describes a display device including a display panel; a cabinet configured to house the display panel; a spacer disposed inside of the cabinet between a back wall of the cabinet and a back portion of the display panel; and a fastening component configured to secure the back wall of the cabinet to the back portion of the display panel by penetrating through the back wall of the cabinet and the spacer and resting in an aperture provided in the back portion of the display panel.

Abstract: Embodiments may comprise logic such as hardware and/or code to adaptively control the transmission power for a wireless channel. In many embodiments, adaptively controlling the transmission power may reduce or, in some embodiments, minimize interference between the wireless display (WiDi) transmissions and other transmissions such as multimedia content streaming over another wireless channel to the notebook via a second generation (2G) channel, third generation (3G) channel, or a future long term evolution (LTE) channel.

Abstract: A determination and query is performed on wireless channel on which video data is transmitted from a transmitting wireless display or WiDi device. Based on a channel capacity and implementing an algorithm, the encoding bit rate at the transmitting WiDi device is adaptively adjusted based on the determined channel capacity.

Abstract: Techniques are disclosed that involve communicating in bursty noise environments. For instance, a source device may send a probing packet to a destination device. This probing packet is for determining whether the communications medium (e.g., one or more frequency channels) is currently exhibiting a busy or jammed (e.g., due to bursty noise) condition. More particularly, based on whether an acknowledgment of the probing packet is received, the source device determines whether the channel is jammed (or busy) or clear. For example, an unacknowledged probing packet indicates that the channel is jammed or busy, while an acknowledged probing packet indicates that the channel is clear. If the channel is determined to be clear, then the source device may transmit one or more data packets to the destination device. Such data packet transmissions may be in accordance with a non rate-adaptive technique.

Abstract: Techniques are described that can be used to perform one or more of the following actions in order to reduce signal interference between WLAN and BlueTooth radios that are proximate to one another. One action is to selectively reduce a filter bandwidth in a WLAN radio applied to a received WLAN radio signal to reduce BlueTooth signal interference. An additional or alternative action is to selectively indicate a WLAN radio channel bandwidth larger than a channel bandwidth used for the WLAN radio so that the BlueTooth radio avoids transmitting over the indicated channel bandwidth. An additional or alternative action is to selectively reduce BlueTooth transmitter power in response to antenna isolation between BT and WLAN radio being less than a first threshold in order to reduce the likelihood of WLAN radio front end saturation.

Abstract: A method, a computer readable medium and an apparatus to adaptively control a data transmission rate of a wireless display device. The method includes determining a current data transmission rate capacity of a wireless channel; and controlling a data transmission rate of a wireless transmission device based on the current data transmission rate capacity.

Abstract: The present invention relates to compound of formula I, II, III, or IV, and/or a pharmaceutical acceptable addition salt thereof and/or a stereoisomer thereof and/or a solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R11, and R12 are as defined in the claim 1. The present invention also relates to a method for their preparation, as well as to pharmaceutical compositions thereof. The present invention further relates to the use of said compounds as biologically active ingredients, more specifically as medicaments for the treatment of disorders and pathologic conditions such as, but not limited to, immune and auto-immune disorders, organ and cells transplant rejections.

Abstract: Techniques are described that can be used to perform one or more of the following actions in order to reduce signal interference between WLAN and BlueTooth radios that are proximate to one another. One action is to selectively reduce a filter bandwidth in a WLAN radio applied to a received WLAN radio signal to reduce BlueTooth signal interference. An additional or alternative action is to selectively indicate a WLAN radio channel bandwidth larger than a channel bandwidth used for the WLAN radio so that the BlueTooth radio avoids transmitting over the indicated channel bandwidth. An additional or alternative action is to selectively reduce BlueTooth transmitter power in response to antenna isolation between BT and WLAN radio being less than a first threshold in order to reduce the likelihood of WLAN radio front end saturation.

Abstract: The invention provides a method of controlling obesity or type two diabetes in a human. In accordance with the inventive method, the constitutive androstane receptor (CAR) is agonized within the human, which effectively controls obesity or type two diabetes.

Abstract: Embodiments of a method and an apparatus for improving the performance of coexisting wireless radio signals are described. In one embodiment, the method includes detecting burst-type interference based on a packet error rate and a transmission rate associated with a transmitter. The method further includes setting the transmission rate in accordance with a burst-type rate adaptation mode to increase data throughput.

Abstract: A computer-implemented method that enables an operation relative to a removable storage medium connected with a computer includes, obtaining an erasing flag to be set to the removable storage medium on the basis of a predetermined rule when the removable storage medium being connected, obtaining a connection time when the removable storage medium is connected, and identifying whether a program being activated on the computer is an erasing program for erasing data stored in the removable storage medium. The computer-implemented method enables concealing, upon the erasing flag is being on and the program being activated being other than the erasing program, data to be erased classified on the basis of the connection time included in the data stored in the removable storage medium.

Abstract: An electronic device includes a main body, a holder, a battery cover, a button and a resilient member. The main body defines an opening and a protruding hole. The holder is fixed to the main body. The battery cover is coupled to the main body and forms a catching tab. The button is slidably positioned between the main body and the holder. The button includes a latching tab. One end of the resilient member resists the holder or the main body, and the other end resists the button. The catching tab of the battery cover protrudes in the protruding hole to engage with the latching tab of the button, and part of the button exposes out of the main body via the opening.

Abstract: Routing in a wireless network of communication devices that are located within a network boundary moves network traffic from a first communication device to a second communication device. A geometric indicator of network connectivity is constructed that identifies a curve on which network nodes are located and a network location for each node of the wireless network is determined, so that the network location of a node p identifies a node on the geometric indicator curve that is closest to the node p and indicates connectivity from the node p to the closest node of the geometric indicator curve. A routing scheme is determined, to route in the wireless network from the first communication device to the second communication device based on the respective determined network locations for the first and second communication devices.

Abstract: Non-steroidal androgen receptor modulating compounds of the general formula (I), their pharmaceutically acceptable salts, preparation process and pharmaceutically compositions containing the said compounds are disclosed. Such compounds of the general formula (I) or their pharmaceutically acceptable salts can be used for preparing non-steroidal medicines to treat and/or prevent conditions or diseases such as prostatic hyperplasia, prostate cancer, hirsutism, severe hormone-dependent alopecia or acne, etc. as a result of androgen receptor antagonistic activities.

Abstract: This invention provides the treatment of viral infections with a 4,6-disubstituted or 2,4,6-trisubstituted quinazoline derivative represented by the structural formula [(I)] wherein: R2 is selected from the group consisting of hydrogen, NR?R? and C1-7 alkyl; —A is selected from the group consisting of a bond, O, S(O)n, C1-7 alkylene, C2-7 alkenylene and C2-7 alkynylene; R4 is selected from the group consisting of C1-7 alkyl, C2-7 alkenyl, C3-10cycloalkyl, C3-10 cycloalkenyl, aryl, heterocyclic, arylalkyl, heterocyclic-substituted alkyl and cycloalkyl-alkyl; —Y is selected from the group consisting of a single bond, C1-7 alkylene, C2-7 alkenylene, and C2-7 alkynylene; n is 0, 1 or 2; and R6 is selected from the group consisting of halogen, heteroaryl and aryl; a pharmaceutically acceptable addition salt, a stereoisomer, a mono- or a di-?/-oxide, a solvate or a pro-drug thereof.

Abstract: Techniques are described that can be used to perform one or more of the following actions in order to reduce signal interference between WLAN and BlueTooth radios that are proximate to one another. One action is to selectively reduce a filter bandwidth in a WLAN radio applied to a received WLAN radio signal to reduce BlueTooth signal interference. An additional or alternative action is to selectively indicate a WLAN radio channel bandwidth larger than a channel bandwidth used for the WLAN radio so that the BlueTooth radio avoids transmitting over the indicated channel bandwidth. An additional or alternative action is to selectively reduce BlueTooth transmitter power in response to antenna isolation between BT and WLAN radio being less than a first threshold in order to reduce the likelihood of WLAN radio front end saturation.

Abstract: This invention provides quinazoline derivatives represented by the structural formula: (I); wherein: R2 is hydrogen, NR?R?, C1-7 alkyl, arylC1-7 alkyl or C3-10 cycloalkyl; R4 is amino, C1-7 alkyl, C2-7 alkenyl, C3-10 cycloalkyl, C3-10 cycloalkenyl, aryl, heterocyclic, arylalkyl, heterocyclic-substituted C1-7 alkyl or C3-10 cycloalkyl-C1-7 alkyl; R5 is hydrogen or C1-7 alkyl, or R5 and R4 together with the nitrogen atom to which they are attached form a heterocyclic ring; Y is a single bond, C1-7alkylene, C2-7 alkenylene or C2-7 alkynylene; R6 is halogen, heteroaryl or aryl; R? and R? are each independently hydrogen, C1-7 alkyl-carbonyl or C1-7 alkyl; provided that R4 is not phenyl substituted with morpholino when R2 is H and R5 is H, and provided that when NR4R5 is piperazinyl, said NR4R5 is either non-substituted or substituted with methyl or acetyl; a pharmaceutically acceptable addition salt, a stereoisomer, a mono- or a di-N-oxide, a solvate or a pro-drug thereof, for the treatment of viral infections.

Abstract: This invention relates to substituted pyrido(3,2-d)pyrimidine derivatives, their pharmaceutically acceptable salts, N-oxides, solvates, pro-drugs and enantiomers, possessing unexpectedly desirable pharmaceutical properties, in particular which are highly active immunosuppressive agents, and as such are useful in the treatment in transplant rejection and/or in the treatment of certain inflammatory diseases. These derivatives are also useful in preventing or treating cardiovascular disorders, disorders of the central nervous system, TNF-? related disorders, viral diseases (including hepatitis C), erectile dysfunction and cell proliferative disorders.

Abstract: This invention relates to substituted pyrido(3,2-d)pyrimidine derivatives, their pharmaceutically acceptable salts, N-oxides, solvates, pro-drugs and enantiomers, possessing unexpectedly desirable pharmaceutical properties, in particular which are highly active immunosuppressive agents, and as such are useful in the treatment in transplant rejection and/or in the treatment of certain inflammatory diseases. These derivatives are also useful in preventing or treating cardiovascular disorders, disorders of the central nervous system, TNF-? related disorders, viral diseases (including hepatitis C), erectile dysfunction and cell proliferative disorders.